Risk factors for proliferative vitreoretinopathy
References (139)
- et al.
Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy
Am. J. Ophthalmol.
(1990) - et al.
Fluorouracil for the treatment of massive periretinal proliferation
Am. J. Ophthalmol.
(1982) - et al.
Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media
Exp. Eye Res.
(1989) - et al.
The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy
Am. J. Ophthalmol.
(1985) - et al.
Proliferative vitreoretinopathy: lymphocytes in epiretinal membranes
Ophthalmology
(1992) - et al.
Inflammatory cells in proliferative vitreoretinopathy subretinal membranes
Ophthalmology
(1993) - et al.
Results and complications of pneumatic retinopexy
Ophthalmology
(1988) The blood-ocular barriers
Surv. Ophthalmol.
(1979)Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier
Exp. Eye Res.
(1977)- et al.
Interleukin-6 gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells
Exp. Eye Res.
(1992)
The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy
Ophthalmology
(1995)
Proliferative vitreoretinopathy: the mechanism of development of vitreoretinal traction
Ophthalmology
(1987)
Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells
Ophthalmology
(1993)
Pneumatic retinopexy failures: cause, prevention, timing, and management
Ophthalmology
(1995)
Clearance of intravitreal fluorouracil: normal and aphakic vitrectomized eyes
Ophthalmology
(1985)
Proliferative vitreoretinopathy membranes: an immunohistochemical study
Ophthalmology
(1989)
Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity
J. Pharm. Sci.
(1990)
Ocular drug bioavailability from topically applied liposomes
Surv. Ophthalmol.
(1985)
An updated classification of retinal detachment with proliferative vitreoretinopathy
Am. J. Ophthalmol.
(1991)
The lack of toxicity of intravitreally administered triamcinolone acetonide
Am. J. Ophthalmol.
(1981)
Complications of endodrainage retinotomies created during vitreous surgery for complicated retinal detachment
Ophthalmology
(1989)
Breakdown of the blood-aqueous barrier after argon laser panretinal photocoagulation for proliferative diabetic retinopathy
Ophthalmology
(1996)
A study on diurnal fluctuation of blood-aqueous barrier permeability to plasma proteins
Exp. Eye Res.
(1993)
Successful scleral buckling procedures decrease central retinal artery blood flow velocity
Ophthalmology
(1993)
Treatment of massive subretinal hemorrhage from complications of scleral buckling procedures
Am. J. Opthalmol.
(1994)
Traction retinal detachment: XLIX Edward Jackson memorial lecture
Am. J. Ophthalmol.
(1993)
Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy
Arch. Ophthalmol.
(1994)
Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy
Invest. Ophthalmol. Vis. Sci.
(1993)
Liposome suppression of proliferative vitreoretinopathy: rabbit model using antimetabolite encapsulated liposomes
Invest. Ophthalmol. Vis. Sci.
(1991)
Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium diethylenetriaminepentaacetic acid injection
Invest. Ophthalmol. Vis. Sci.
(1991)
Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI
Invest. Ophthalmol. Vis. Sci.
(1992)
Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil
Graefe's Arch. Clin. Exp. Ophthalmol.
(1983)
Results and prognostic in pneumatic retinopexy
German J. Ophthalmol.
(1994)
Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment
Ophthalmologica
(1984)
The development of severe proliferative vitreoretinopathy after retinal detachment surgery, Grade B: a determining risk factor
Graefe's Arch. Clin. Exp. Ophthalmol.
(1988)
Macular changes and fluorescein angiographic findings after repair of proliferative vitreoretinopathy
Retina
(1994)
Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR
Graefe's Arch. Clin. Exp. Ophthalmol.
(1995)
Platelet-derived growth factors is chemotactic for human retinal pigment epithelial cells
Arch. Ophthalmol.
(1985)
Serum contains chemoattractants for human retinal pigment epithelial cells
Arch. Ophthalmol.
(1984)
Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells
Arch. Ophthalmol.
(1985)
Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration
Arch. Ophthalmol.
(1985)
Intravitreal chemotactic and mitogenic activity: implication of blood-retinal barrier breakdown
Arch. Ophthalmol.
(1986)
Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound
Arch. Ophthalmol.
(1987)
Platelet-derived growth factor is an autocrine growth stimulator in retinal pigment epithelial cells
J. Cell Sci.
(1994)
Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes
Invest. Ophthalmol. Vis. Sci.
(1985)
Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment
Graefe's Arch. Clin. Exp. Ophthalmol.
(1987)
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment
Br. J. Ophthalmol.
(1995)
Clinical risk factors for proliferative vitreoretinopathy
Arch. Ophthalmol.
(1989)
Uveal blood flow after 360°
Arch. Ophthalmol.
(1980)
Multiple control of inflammation by glucocorticoids
Agents Actions
(1985)
Cited by (153)
Retinotomies and retinectomies: A review of indications, techniques, results, and complications
2023, Survey of OphthalmologyIn vitro laboratory models of proliferative vitreoretinopathy
2023, Survey of OphthalmologyEffect of race and ethnicity on surgical outcomes for rhegmatogenous retinal detachments
2023, Canadian Journal of OphthalmologyLong-acting formulation strategies for protein and peptide delivery in the treatment of PSED
2022, Journal of Controlled Release
Copyright © 1997 Published by Elsevier Ltd.